USD10
ALLO acciones
Acerca de Allogene TherapeuticsAllogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
USD10
ALLO acciones
Acerca de Allogene TherapeuticsAllogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
23 mar at 13:30 GMT+0
CAPITALIZACIÓN DE MERCADO
548,48 M US$
PRECIO DE APERTURA
2,14 US$
BAJO (1Y)
0,8621 US$
ALTO (1Y)
2,80 US$
BAJO (24H)
2,13 US$
Alza (24H)
2,60 US$
Volumen (24 h)
11,68 M US$
43,7 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | 2,14 US$ | |
1 día | 2,14 US$ | |
1 semana | 2,49 US$ | |
1 mes | 2,10 US$ | |
1 año | 1,68 US$ |
Una nueva era de Coinbase ha comenzado
El futuro del dinero está aquí. Sé uno de los primeros en obtener acceso y probar nuevas funciones en cuanto estén disponibles.
Crea una cuenta ahora